← Eichor
Study identifier: NCT07276867 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

Condition: Intrathecal · Dexmedetomidine · Fentanyl  ·  Sponsor: National Cancer Institute, Egypt

PhaseNA
Planned participants58
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

The current work evaluated whether the combination of intrathecal dexmedetomidine and fentanyl provides superior postoperative analgesia to fentanyl alone when administered with hyperbaric bupivacaine.

This description comes directly from the study's public registry record.

Talk to the study team

Mai M Elrawas, MD  ·  00201222177242  ·  mai.elrawas@nci.cu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

National Cancer InstituteCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07276867